Save time and get answers to complex questions with AI chat
How to apply for vascepa's patient assistance?Abbvie humira patent cliff navigation success?When is tenofovir alafenamide patent expiring?Zemdri nce gain exclusivity 2028 patent 2031?Drugpatentwatch skyrizi biologic patent analysis?
See the DrugPatentWatch profile for Daytrana
Daytrana is a transdermal methylphenidate patch that is applied to the hip area. The label guidance is to place it on the hip, and to rotate sites to help reduce irritation at the application area.
You can use either hip. The key instruction is to rotate between hip locations rather than using the exact same spot each time.
No. The patch is designed to be applied to the hip area as directed. Don’t place it on other body parts.
Rotate the hip placement sites and avoid reusing the same exact skin spot. If the skin becomes irritated, follow the prescriber’s or product-label instructions for managing application-area reactions.
Placing the patch outside the recommended hip area can affect how the medicine delivers through the skin, which may reduce effectiveness and increase the chance of local skin problems.
Apply the Daytrana patch to the hip area and rotate the placement site between uses. Sources: None provided in the prompt.
Other Questions About Daytrana :